TIBCO Speeds Drug Discovery for Chemists( TIBCO Spotfire Lead Discovery pro...)

TIBCO Spotfire Lead Discovery provides an easy-to-use, highly visual and interactive environment for exploring chemical structures and any associated data

SOMERVILLE, Mass., Nov. 11 /PRNewswire-FirstCall/ -- TIBCO Software Inc. (Nasdaq: TIBX), today announced the release of TIBCO Spotfire(R) Lead Discovery. The solution allows chemists to quickly access chemistry and biological data in a single analysis environment, then easily build best-practice applications for chemical structure analysis. The solution, built on the powerful TIBCO Spotfire(R) Enterprise Analytics platform, integrates with leading cheminformatics software, including Symyx and CambridgeSoft.

In order to determine which compounds to synthesize to optimize the drug discovery and development process, chemists must evaluate an increasing number of parameters - from chemical properties and biological assays to absorption and excretion (ADME) results. Spotfire(R) Lead Discovery offers intuitive data representations and best practice analytics processes that any chemist can use to quickly ask and answer their own questions of their data.

"Spotfire Lead Discovery enhances a chemist's intuition and expertise in deciphering complex problems and driving faster, more efficient drug discovery, enabling them to work more flexibly with the disparate technologies and data sources used in analysis today," said Christian Marcazzo, senior director, Industry Solutions Life Sciences, Spotfire Division of TIBCO Software Inc.

Visual, Interactive Analysis Helps Chemists Focus on Scientific Questions Instead of Software

With TIBCO Spotfire(R), chemists can visualize and explore relationships between chemistry and biological data - as well as other relevant info
'/>"/>